Literature DB >> 19960623

Pandemic influenza A (H1N1) 2009 virus vaccine - conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19960623

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  13 in total

1.  Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Authors:  Sharon E Frey; David I Bernstein; Michael A Gerber; Harry L Keyserling; Flor M Munoz; Patricia L Winokur; Christine B Turley; Richard E Rupp; Heather Hill; Mark Wolff; Diana L Noah; Allison C Ross; Gretchen Cress; Robert B Belshe
Journal:  J Infect Dis       Date:  2012-07-16       Impact factor: 5.226

2.  Review of the status and challenges associated with increasing influenza vaccination coverage among pregnant women in China.

Authors:  Suizan Zhou; Carolyn M Greene; Ying Song; Ran Zhang; Lance E Rodewald; Luzhao Feng; Alexander J Millman
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

3.  Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum.

Authors:  Rhoda S Sperling; Stephanie M Engel; Sylvan Wallenstein; Thomas A Kraus; Jose Garrido; Tricia Singh; Lisa Kellerman; Thomas M Moran
Journal:  Obstet Gynecol       Date:  2012-03       Impact factor: 7.661

Review 4.  Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.

Authors:  Jördis J Ott; Janna Klein Breteler; John S Tam; Raymond C W Hutubessy; Mark Jit; Michiel R de Boer
Journal:  Hum Vaccin Immunother       Date:  2013-05-31       Impact factor: 3.452

5.  Patient reported outcome data following influenza A (H1N1p) vaccination in the 2009-2010 season: web-based and telephone evaluation.

Authors:  Alan G Wade; Gordon M Crawford; Neil Pumford; Alex McConnachie
Journal:  Ther Clin Risk Manag       Date:  2011-10-21       Impact factor: 2.423

6.  Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults.

Authors:  Hideyuki Ikematsu; Hideaki Nagai; Masahiro Kawashima; Yasunobu Kawakami; Kazuyoshi Tenjinbaru; Ping Li; Karl Walravens; Paul Gillard; François Roman
Journal:  Hum Vaccin Immunother       Date:  2012-02-01       Impact factor: 3.452

7.  The Lao Experience in Deploying Influenza A(H1N1)pdm09 Vaccine: Lessons Made Relevant in Preparing for Present Day Pandemic Threats.

Authors:  Anonh Xeuatvongsa; Sara Mirza; Christian Winter; Keith Feldon; Phengta Vongphrachanh; Darouny Phonekeo; Justin Denny; Viengphone Khanthamaly; Bounheuang Kounnavong; Doualy Lylianou; Sisouphane Phousavath; Sisouveth Norasingh; Nao Boutta; Sonja Olsen; Joseph Bresee; Ann Moen; Andrew Corwin
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

8.  Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: an observer-blind, randomized trial.

Authors:  William H Yang; Marc Dionne; Michael Kyle; Naresh Aggarwal; Ping Li; Miguel Madariaga; Olivier Godeaux; David W Vaughn
Journal:  Vaccine       Date:  2013-07-12       Impact factor: 3.641

9.  Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan.

Authors:  Yu-Jiun Chan; Chia-Ling Lee; Shinn-Jang Hwang; Chang-Phone Fung; Fu-Der Wang; David H T Yen; Cheng-Hsien Tsai; Yi-Ming Arthur Chen; Shou-Dong Lee
Journal:  J Chin Med Assoc       Date:  2010-02       Impact factor: 2.743

Review 10.  The first influenza pandemic of the 21st century.

Authors:  Sami Al Hajjar; Kenneth McIntosh
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.